Molecular labs continue to gain ground with insurers. This summer, 8 more genetic assays received positive coverage decisions—4 from Medicare and 4 from private insurers. The winners included Genomic Health, CareDx, Myriad Genetics, Castle Biosciences, Interpace Diagnostics and NanoString Technologies. Here’s a rundown of the key details. The Medicare Approvals Four of the approvals came…

This content is for Paid Members only.
Login Register